DE69726714T2 - 9-oximsilyl erythromycin a derivate - Google Patents

9-oximsilyl erythromycin a derivate Download PDF

Info

Publication number
DE69726714T2
DE69726714T2 DE69726714T DE69726714T DE69726714T2 DE 69726714 T2 DE69726714 T2 DE 69726714T2 DE 69726714 T DE69726714 T DE 69726714T DE 69726714 T DE69726714 T DE 69726714T DE 69726714 T2 DE69726714 T2 DE 69726714T2
Authority
DE
Germany
Prior art keywords
erythromycin
oximsilyl
derivate
alkylerythromycin
oximesilyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69726714T
Other languages
English (en)
Other versions
DE69726714D1 (en
Inventor
Yi-Yin Ku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24510750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69726714(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69726714D1 publication Critical patent/DE69726714D1/de
Publication of DE69726714T2 publication Critical patent/DE69726714T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69726714T 1996-04-02 1997-02-06 9-oximsilyl erythromycin a derivate Expired - Fee Related DE69726714T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/626,524 US5837829A (en) 1996-04-02 1996-04-02 9-oximesilyl erythromycin a derivatives
PCT/US1997/001955 WO1997036913A1 (en) 1996-04-02 1997-02-06 9-oximesilyl erythromycin a derivatives

Publications (2)

Publication Number Publication Date
DE69726714D1 DE69726714D1 (en) 2004-01-22
DE69726714T2 true DE69726714T2 (de) 2004-10-07

Family

ID=24510750

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69726714T Expired - Fee Related DE69726714T2 (de) 1996-04-02 1997-02-06 9-oximsilyl erythromycin a derivate

Country Status (10)

Country Link
US (1) US5837829A (de)
EP (1) EP0891371B1 (de)
JP (2) JP2000507574A (de)
AT (1) ATE256138T1 (de)
CA (1) CA2250771C (de)
DE (1) DE69726714T2 (de)
DK (1) DK0891371T3 (de)
ES (1) ES2212808T3 (de)
PT (1) PT891371E (de)
WO (1) WO1997036913A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
ATE272646T1 (de) 1996-07-29 2004-08-15 Abbott Lab Herstellung von kristallinen form ii von clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
AU2274799A (en) * 1997-12-22 1999-07-12 Biochemie S.A. Intermediates in macrolide production
KR100283990B1 (ko) * 1998-12-29 2001-03-02 민경윤 에리스로마이신 a 유도체 및 그의 제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB9915745D0 (en) * 1999-07-06 1999-09-08 Biochemie Sa Organic compounds
EP1254146B1 (de) * 1999-12-16 2005-08-24 Teva Pharmaceutical Industries Ltd. Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
PT1280535E (pt) * 2000-01-11 2005-04-29 Teva Pharma Processos para a preparacao de polimorfos de claritromicina
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
CA2401571A1 (en) * 2000-02-29 2001-09-07 Ilya Avrutov Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
BR0109194A (pt) * 2000-03-15 2003-02-11 Hanmi Pharm Ind Co Ltd Método para preparar claritromicina em cristais da forma ii
KR100367981B1 (ko) * 2000-11-23 2003-01-14 한미약품공업 주식회사 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
EP1648407A4 (de) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
JP2006528189A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653925A1 (de) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robustes pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1658034A4 (de) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
PL2182983T3 (pl) 2007-07-27 2014-10-31 Janssen Alzheimer Immunotherap Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharmaceutical Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법

Also Published As

Publication number Publication date
JP2000507574A (ja) 2000-06-20
DK0891371T3 (da) 2004-04-13
CA2250771C (en) 2006-05-02
PT891371E (pt) 2004-04-30
WO1997036913A1 (en) 1997-10-09
CA2250771A1 (en) 1997-10-09
ATE256138T1 (de) 2003-12-15
ES2212808T3 (es) 2004-08-01
EP0891371B1 (de) 2003-12-10
US5837829A (en) 1998-11-17
JP2007224035A (ja) 2007-09-06
EP0891371A1 (de) 1999-01-20
DE69726714D1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
ATE256138T1 (de) 9-oximsilyl erythromycin a derivate
ATE231851T1 (de) 6-o-alkyl erythronolid-b derivate
NO903656D0 (no) Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner.
FI931427A0 (fi) Ny onkofetal gen, genprodukt och anvaendningen daerav
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
FI882397A0 (fi) Vaccin och framstaellningsfoerfarande.
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
TR23145A (tr) Diflufenican kullanan herbisidal usul
NO901832D0 (no) Fremgangsmaate for fremstilling av polyketon.
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO871759D0 (no) Fremgangsmaate for fremstilling av sucralfat-preparater.
DE69031181T2 (de) Perylenequinon (UCN-1028D) Derivate
DE69011268T2 (de) Diflourobenzonitril Derivate.
NO900969D0 (no) Fremgangsmaate for fremstilling av anilin-derivat.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
FI971964A (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
NO903196D0 (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.
NO167387C (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivat.
DE69007317D1 (de) Difluoroalkylcyclohexyl-benzonitril Derivate.
NO890216D0 (no) Fremgangsmaate for revitalisering av forstkulturer.
NO880167D0 (no) Fremgangsmaate for fremstilling av benzotiazindioksyd-derivater.
UA25100A (uk) Припрацювальhа суміш
DK136386D0 (da) Hoejttaler, navnlig bashoejttaler
FI874249A0 (fi) Foerfarande foer framstaellning av 3-dimetylamino-7-metyl-1,2,4-bensotriazin-1-oxid och azapropazon.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee